Editas Medicine (EDIT) EBIT Margin Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3,724.00 |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10.73 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 426,719.00 |
| Dec 31, 2024 | -11,234.00 |
| Sep 30, 2024 | -10.67 Mn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -538,497.00 |
| Dec 31, 2023 | 93,081.00 |
| Sep 30, 2023 | 13.60 Mn |
| Jun 30, 2023 | -67,486.00 |
| Mar 31, 2023 | 23,220.00 |
| Dec 31, 2022 | -63,701.00 |
| Sep 30, 2022 | -13.63 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 12,574.00 |
| Dec 31, 2021 | 24,316.00 |
| Sep 30, 2021 | -64,772.00 |
| Jun 30, 2021 | -1.43 Mn |
| Mar 31, 2021 | -6,072.00 |
| Dec 31, 2020 | -25,594.00 |
| Sep 30, 2020 | 91,316.00 |
| Jun 30, 2020 | 123,845.00 |
| Mar 31, 2020 | 69,643.00 |
| Dec 31, 2019 | 10,812.00 |
| Sep 30, 2019 | -78,688.00 |
| Jun 30, 2019 | -99,206.00 |
| Mar 31, 2019 | -70,733.00 |
| Sep 30, 2018 | 31,383.00 |
| Jun 30, 2018 | 30,529.00 |
| Mar 31, 2018 | 368,712.00 |
| Sep 30, 2017 | 177,430.00 |
| Jun 30, 2017 | -27,653.00 |
| Mar 31, 2017 | -227,474.00 |
| Dec 31, 2016 | -277,896.00 |
| Sep 30, 2016 | -109,831.00 |
| Jun 30, 2016 | 565,844.00 |